Weldon Steven W 4
4 · GT Biopharma, Inc. · Filed Dec 23, 2020
Insider Transaction Report
Form 4
Weldon Steven W
DirectorCFO
Transactions
- Sale
Common Stock
2020-12-21$0.30/sh−50,000$15,000→ 3,853,700 total - Sale
Common Stock
2020-12-21$0.33/sh−50,000$16,500→ 3,803,700 total - Sale
Common Stock
2020-12-21$0.34/sh−35,722$12,145→ 3,767,978 total - Sale
Common Stock
2020-12-22$0.40/sh−47,978$19,191→ 3,720,000 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.